DC-CIK

· Beijing Biohealthcare Biotechnology Co.,Ltd

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for DC-CIK, covering 2015-07-21 to 2024-01-10. Get the full timeline:

Most recent: Clinical Trial Update: Combined S-1 With DC+CIK As Maintenance Therapy For Advanced Pancreatic Ductal Adenocarcinoma [Phase 2, Phase 3]